Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report) have been assigned an average recommendation of “Hold” from the eighteen brokerages that are covering the stock, Marketbeat reports. Fifteen investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1 year price […]
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) had its target price hoisted by equities researchers at The Goldman Sachs Group from $22.00 to $25.00 in a report issued on Friday, Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. The Goldman Sachs Group’s price objective would suggest a potential upside […]
Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report) have received a consensus rating of “Hold” from the twenty research firms that are currently covering the company, Marketbeat.com reports. Seventeen equities research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 […]
Bank of America Cuts Sage Therapeutics (NASDAQ:SAGE) Price Target to $24 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) had its price target lowered by research analysts at Royal Bank of Canada from $25.00 to $22.00 in a note issued to investors on Thursday, FlyOnTheWall reports. Royal Bank of Canada’s target price would suggest a potential upside of 6.59% from the stock’s previous close. Several other analysts […]